A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): Impact of radiation and cisplatin intensity on outcome.
Authors:
- K. AngKAK. Ang
- Q. ZhangQZQ. Zhang
- R. H. WheelerRWR. H. Wheeler
- D. I. RosenthalDRD. I. Rosenthal
- F. Nguyen-TanFNF. Nguyen-Tan
- H. KimHKH. Kim
- C. LuCLC. Lu
- R. S. AxelrodRAR. S. Axelrod
- C. I. SilvermanCSC. I. Silverman
- R. S. WeberRWR. S. Weber
- 20 May 2010
- journal article
- abstracts
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (15_suppl) , 5507